Literature DB >> 27130484

Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans.

Wei-Ching Huang1, Jie Liang1, Masayuki Nagahashi2, Dorit Avni1, Akimitsu Yamada2, Michael Maceyka1, Aaron R Wolen3, Tomasz Kordula1, Sheldon Milstien1, Kazuaki Takabe2, Tamas Oravecz4, Sarah Spiegel5.   

Abstract

The bioactive sphingolipid sphingosine-1-phosphate (S1P) and the kinase that produces it have been implicated in inflammatory bowel diseases in mice and humans; however, little is known about the role of the 2 S1P-specific phosphohydrolase isoforms, SGPP1 and SGPP2, which catalyze dephosphorylation of S1P to sphingosine. To elucidate their functions, we generated specific knockout mice. Deletion of Sgpp2, which is mainly expressed in the gastrointestinal tract, significantly reduced dextran sodium sulfate (DSS)-induced colitis severity, whereas deletion of ubiquitously expressed Sgpp1 slightly worsened colitis. Moreover, Sgpp1 deletion enhanced expression of multifunctional proinflammatory cytokines, IL-6, TNF-α, and IL-1β, activation of the transcription factor signal transducer and activator of transcription 3, and immune cell infiltration into the colon. Conversely, Sgpp2-null mice failed to mount a DSS-induced systemic inflammatory response. Of interest, Sgpp2 deficiency suppressed DSS-induced intestinal epithelial cell apoptosis and improved mucosal barrier integrity. Furthermore, down-regulation of Sgpp2 attenuated LPS-induced paracellular permeability in cultured cells and enhanced expression of the adherens junction protein E-cadherin. Finally, in patients with ulcerative colitis, SGPP2 expression was elevated in colitis tissues relative to that in uninvolved tissues. These results indicate that induction of SGPP2 expression contributes to the pathogenesis of colitis by promoting disruption of the mucosal barrier function. SGPP2 may represent a novel therapeutic target in inflammatory bowel disease.-Huang, W.-C., Liang, J., Nagahashi, M., Avni, D., Yamada, A., Maceyka, M., Wolen, A. R., Kordula, T., Milstien, S., Takabe, K., Oravecz, T., Spiegel, S. Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans. © FASEB.

Entities:  

Keywords:  S1P; SGPP1; SGPP2; inflammatory bowel disease

Mesh:

Substances:

Year:  2016        PMID: 27130484      PMCID: PMC4970610          DOI: 10.1096/fj.201600394R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  48 in total

Review 1.  Genetics and pathogenesis of inflammatory bowel disease.

Authors:  Bernard Khor; Agnès Gardet; Ramnik J Xavier
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

2.  The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.

Authors:  Yasuyuki Deguchi; Akira Andoh; Yuki Yagi; Shigeki Bamba; Osamu Inatomi; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  Oncol Rep       Date:  2006-10       Impact factor: 3.906

Review 3.  The risk of cancer in patients with Crohn's disease.

Authors:  Alexander C von Roon; George Reese; Julian Teare; Vasilis Constantinides; Ara W Darzi; Paris P Tekkis
Journal:  Dis Colon Rectum       Date:  2007-06       Impact factor: 4.585

4.  FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.

Authors:  Carolin Daniel; Nico A Sartory; Nadine Zahn; Ronald Schmidt; Gerd Geisslinger; Heinfried H Radeke; Jurgen M Stein
Journal:  Mol Immunol       Date:  2007-05-01       Impact factor: 4.407

5.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

6.  Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats.

Authors:  Antonella Vetuschi; Giovanni Latella; Roberta Sferra; Renzo Caprilli; Eugenio Gaudio
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

7.  Sphingosine-1-phosphate phosphatase 1 regulates keratinocyte differentiation and epidermal homeostasis.

Authors:  Maria L Allende; Laura M Sipe; Galina Tuymetova; Kelsey L Wilson-Henjum; Weiping Chen; Richard L Proia
Journal:  J Biol Chem       Date:  2013-05-01       Impact factor: 5.157

Review 8.  Sphingosine-1-phosphate and lipid phosphohydrolases.

Authors:  Hervé Le Stunff; Courtney Peterson; Hong Liu; Sheldon Milstien; Sarah Spiegel
Journal:  Biochim Biophys Acta       Date:  2002-05-23

9.  Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide.

Authors:  Paola Giussani; Michael Maceyka; Hervé Le Stunff; Aki Mikami; Sandrine Lépine; Elaine Wang; Samuel Kelly; Alfred H Merrill; Sheldon Milstien; Sarah Spiegel
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

10.  Distinct roles for hematopoietic and extra-hematopoietic sphingosine kinase-1 in inflammatory bowel disease.

Authors:  Ashley J Snider; Wahida H Ali; Jonathan A Sticca; Nicolas Coant; Amr M Ghaleb; Toshihiko Kawamori; Vincent W Yang; Yusuf A Hannun; Lina M Obeid
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

View more
  22 in total

1.  Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity.

Authors:  Stephanie Oertel; Klaus Scholich; Andreas Weigert; Dominique Thomas; Julia Schmetzer; Sandra Trautmann; Marthe-Susanna Wegner; Heinfried H Radeke; Natalie Filmann; Bernhard Brüne; Gerd Geisslinger; Irmgard Tegeder; Sabine Grösch
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

Review 2.  Sphingolipid metabolism in cancer signalling and therapy.

Authors:  Besim Ogretmen
Journal:  Nat Rev Cancer       Date:  2017-11-17       Impact factor: 60.716

3.  Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment.

Authors:  Mel Pilar Espaillat; Ashley J Snider; Zhijuan Qiu; Breana Channer; Nicolas Coant; Edward H Schuchman; Richard R Kew; Brian S Sheridan; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2017-12-19       Impact factor: 5.191

4.  Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.

Authors:  Jung H Suh; Émilie Degagné; Elizabeth E Gleghorn; Mala Setty; Alexis Rodriguez; K T Park; Sofia G Verstraete; Melvin B Heyman; Ashish S Patel; Melissa Irek; Ginny L Gildengorin; Neil E Hubbard; Alexander D Borowsky; Julie D Saba
Journal:  Inflamm Bowel Dis       Date:  2018-05-18       Impact factor: 5.325

Review 5.  Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.

Authors:  Mel Pilar Espaillat; Richard R Kew; Lina M Obeid
Journal:  Adv Biol Regul       Date:  2016-11-14

Review 6.  The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.

Authors:  Masayuki Nagahashi; Kizuki Yuza; Yuki Hirose; Masato Nakajima; Rajesh Ramanathan; Nitai C Hait; Phillip B Hylemon; Huiping Zhou; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Lipid Res       Date:  2016-07-26       Impact factor: 5.922

7.  Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.

Authors:  Eriko Katsuta; Li Yan; Masayuki Nagahashi; Ali Raza; Jamie L Sturgill; Debra E Lyon; Omar M Rashid; Nitai C Hait; Kazuaki Takabe
Journal:  J Surg Res       Date:  2017-06-29       Impact factor: 2.192

Review 8.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 9.  Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.

Authors:  Tamara Pérez-Jeldres; Manuel Alvarez-Lobos; Jesús Rivera-Nieves
Journal:  Drugs       Date:  2021-05-13       Impact factor: 11.431

Review 10.  The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy.

Authors:  Megan Sheridan; Besim Ogretmen
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.